BioMarin Pharmaceutical (NASDAQ:BMRN) reported second-quarter 2026 revenue of nearly $1 billion, up 20% from a year earlier, as growth across its rare-disease portfolio and the recently completed Amicus acquisition supported results. The company raised its full-year revenue, VOXZOGO revenue and non-
CarGurus (NASDAQ:CARG) reported second-quarter 2026 revenue of $251 million, up 13% from a year earlier and above the midpoint of its guidance range, as adoption of add-on dealer products and international growth supported results. Adjusted EBITDA rose 7% to $85 million, representing a 34% margin, w
AvePoint (NASDAQ:AVPT) reported second-quarter 2026 revenue and annual recurring revenue growth that exceeded its guidance, as the company highlighted rising demand for governance, security and recovery tools tied to enterprise adoption of artificial intelligence.
Total revenue rose 22% year over y
Bridger Aerospace Group (NASDAQ:BAER) reported second-quarter revenue that was essentially unchanged from a year earlier, while reiterating its full-year outlook and citing increasing wildfire activity, longer-duration government task orders and expansion into aircraft modification and intelligence
Better Home & Finance (NASDAQ:BETR) reported higher loan volume and revenue for the second quarter of 2026, while outlining a more cautious third-quarter outlook amid elevated mortgage rates, delayed partnership launches and a muted refinancing market.
The company also disclosed a leadership tr
Blink Charging (NASDAQ:BLNK) reported second-quarter results marked by sharply higher gross margins, lower operating expenses and a narrower adjusted EBITDA loss, while reducing its full-year revenue outlook following the divestiture of Envoy Technologies and a greater emphasis on higher-margin busi
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported second-quarter 2026 revenue growth, supported by recently launched products including ipratropium bromide inhalation, while management said it is addressing an FDA warning letter at its IMS subsidiary and continuing investments in its pipeline and U.S
Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrang
Atlanticus (NASDAQ:ATLC) reported record second-quarter profit and revenue as the consumer-credit company continued to expand its legacy businesses and integrate the Mercury acquisition.
Net income attributable to common shareholders rose 67% year over year to $47.4 million, or $2.50 per diluted sh
Airbnb (NASDAQ:ABNB) reported second-quarter 2026 results that exceeded its outlook, with revenue rising 17% year over year to $3.6 billion and gross booking value increasing 16% to $27.2 billion. Nights and seats booked grew 10%, accelerating from the first quarter, while adjusted EBITDA reached $1
With their resilient business models, reliable cash flows, consistent dividend growth, and solid long-term growth prospects, these three blue-chip stocks offer compelling buying opportunities for long-term investors.
Business development company Main Street Capital (NYSE:MAIN) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 3.9% year ...
On Aug. 6, 2026, the voice AI platform posted $61.9M quarterly revenue and extended its post-earnings rally on expanded partnerships across multiple sectors.
